FYR Diagnostics is focused on developing the next generation of liquid biopsy solutions by harnessing the innovative properties of Extracellular Vesicles (EVs) and other revolutionary biomarkers. FYR is building a clinically focused universal multi-omics platform that reveals EV-based data insights, offering diagnostic and pharmaceutical applications across multiple disease areas. FYR’s approach increases clinical utility by enabling improvements on early detection, prognosis, recurrence monitoring, treatment guidance and monitoring, and novel target discovery for drug development. For more information, visit fyrdiagnostics.com.
